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Introduction: All patients who underwent the endovascular treatment of abdominal aortic
aneurysm require regular check-ups for possible occurrence of endoleak and further growth
of the aneurysm. Such check-ups are performed in most cases by CT imaging with the
administration of a contrast agent which may cause allergies or impairment of renal
functions. CT itself represents a signiﬁcant radiation dose incurred by the patient. When
contrast-enhanced ultrasound (CEUS) is used, patients are exposed neither to these risks nor
to X-ray radiation.
Objective: Verify the diagnostic recovery of contrast-enhanced ultrasound for the monitor-
ing of patients after the endovascular treatment of abdominal aortic aneurysms.
Method: Since January 2014 we have been qualifying patients for a prospective study. All
patients who have been implanted a stent graft for the infrarenal aortic aneurysm since
January 2014 and patients who were implanted a stent graft earlier but who have undergone
a check-up since January 2014 are qualiﬁed for the study. These patients are always checked
up after the surgery by CT angiography and CEUS as well. 16 patients have been qualiﬁed for
the study so far. After the application of a stent graft we examine our patients before they are
discharged from the hospital and 1, 6 and 12 months after the surgery. CEUS is performed by
2 physicians only.
Results: In the 16 patients a total of 28 check-ups have been conducted (1 check-up without
contrast medium). In 9 patients (13 CTA examinations and 12 CEUS) endoleak was proven
(1 of the I-type, 8 of the II-type). In the case of 2 examinations consistency between CTA and
CEUS was not proven – 7.4%. In one case the inconsistency concerned the type of endoleak
and in the other case, CTA erroneously described endoleak which was not obvious from
CEUS. When measuring the size of an aneurysm sack, we observed signiﬁcant differences
between CTA and CEUS ( p < 0.001). The CEUS examination was assessable even in the case
of obese patients.
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Conclusion: We have observed a 100% consistency in the result of 25 examinations which
used both methods. Based on the comparisons between CEUS and CTAG performed so far,
CEUS seems to be a reliable method which could be used within the framework of dispensary
care for patients after endovascular aneurysm repair (EVAR). CEUS seems to be sensitive
enough to detect endoleak. However, to be able to provide a reliable evaluation, a larger set of
patients and longer-term experience are needed, speciﬁcally for the evaluation of the
aneurysm sack size.
# 2015 The Czech Society of Cardiology. Published by Elsevier Sp. z o.o. All rights
reserved.
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.Introduction
We have had the opportunity to study the application of stent
grafts (EVAR) for abdominal aortic aneurysm – AAA [1] for
thirty years. In the last decade we have seen a signiﬁcant
increase in the number of EVAR compared to open resections
of AAA. The endovascular implantation method is being
improved on a continuous basis and new methods and stent
grafts are being developed. New technologies and materials
are used. All the aforementioned aspects result in the
extension of indications where we apply the endovascular
treatment. EVAR is not used only in patients with the so-
called ideal anatomy, but we also treat patients whose
anatomical handicap would have practically contraindicated
the use of a stent graft in the past [2]. We are not only able to
use the endovascular  treatment in the case of aneurysms with
‘‘unsuitable’’ neck, but due to the new types of stent grafts
with branches or fenestrations, we are able to resolve aortic
impairments in the place of the division of the visceral
branches [3]. Using the endovascular treatment we are also
able to treat certain types of complications resulting from
vascular surgeries performed in the aortic area. We have been
meeting patients with implanted stent grafts and we are going
to meet them more often in the future. On the other hand, we
will meet complications of the endovascular treatment more
often in the future as well. We are able to solve a number of
complications by means of endovascular treatment but there
are some which require a surgery. Some types of complica-
tions related to EVAR do not require any speciﬁc treatment but
the patients must be checked up regularly and their
development monitored [3,4]. On the other hand, there are
very serious complications in the case of which early
diagnostics and proper treatment are crucial from the point
of view of the patient's life. As it is obvious from the above
mentioned, consistent control of patients with an implanted
stent graft is of great importance. Most EVAR-related
complications are not detectable based on anamnestic data
or clinical examination. For this reason, the monitoring must
be always completed with imaging examination. The selec-
tion of imaging examination may differ depending on the
customary approach of individual centres. It is possible to use
one of the imaging methods or a combination thereof. CT
angiography using iodine-based contrast medium is applied
very often. In this case the patients are exposed to the riskof allergic reaction, nephropathy and a potential risk related
to the dose of ionizing radiation absorbed during the
examination [5–9].
Methods
A prospective monocentric study focused on the comparison
of the results of data acquired from the monitoring of patients
after EVAR using CT angiography and contrast-enhanced
ultrasound (CEUS) is concerned. The patients have been
included in the study since January 2014. All patients with
implanted stent graft since January 2014 are eligible. These
patients undergo clinical examination and computed tomog-
raphy angiography (CTAG) and also CEUS always prior to
discharge and later after 1, 6 and 12 months within the
framework of check-ups. The other patients who are included
in the study, are those who underwent EVAR earlier and who
underwent check-ups in the course of 2014. These follow-up
controls include examinations using both methods as well.
EVARs are performed by a team of a vascular surgeon and an
interventional radiologist, always under general anaesthesia
and with antibiotic prophylaxis. The parameter monitored
during examinations is the size of the AAA sack, the presence
or absence of endoleak and type thereof and, where applicable,
other possible complications (e.g. thrombosis, stenosis, break
or disconnection of the stent graft). The CTAG evaluation is
performed by physicians – employees of the Department of
Imaging Methods of the Teaching Hospital and Faculty of
Medicine in Pilsen. Considering the total lower number of
performed examinations and the experience, CEUS is per-
formed by only 2 physicians working at the Department of
Imaging Methods. Ultrasound examination is conducted with
the instruments Siemens Acuson Antares (a CH4-1 convex
probe working at frequencies 1–4 MHz) and Siemens Acuson S
2000 (a 4C1 convex probe working at frequencies 1–4.5 MHz)
and the SonoVue contrast medium produced by Bracco. All
patients who have been enrolled in the study so far had
aneurysmal dilatation of the infrarenal aorta or/and the pelvic
arteries and for all of them the aortoiliac conﬁguration of the
stent graft was selected although this stent graft conﬁguration
is not the criterion for the qualiﬁcation for the study. In none of
the patients, a fenestrated or a branched stent graft was
implanted. No anamnestic or demographic data excluded the
possibility to include the patient in the study. The Statistika
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of the study.
Results
In the period under review a total of 16 patients were included
in the study. 2 patients underwent the surgery in 2013, 1
patient in 2003 and 13 patients in 2014. At the scheduled
intervals we performed a total 27 examinations using both
methods (CTAG + CEUS) in these patients and 1 female
patient underwent 1 examination performed using both
methods in a native way (CT + ultrasonography without
contrast medium) due to repeatedly impossible peripheral
venous access.
(a) Endoleak: In 9 patients endoleak was detected during
examinations. In 13 cases during CTAG examinations and
in 12 cases during CEUS examinations (and also in one case
during the ultrasound without contrast agent but only with
Doppler imaging). Table 1 provides the frequencies of the
individual types of endoleak. In two patients we observed
some development in the course of the series of examina-
tions. In one case a positive development was concerned
where endoleak disappeared (CTAG and CEUS generated
consistent results) and on the other hand, in one case we
detected endoleak after a series of examinations in the 6th
postoperative month (CTAG and CEUS generated consis-
tent results). In two examinations performed using both
methods – 7.4% (2/27) in 2 different patients – 12.5% (2/16)
we observed inconsistency of results generated by CTAG
and CEUS. In one case CEUS failed to detect endoleak of
type II which was described by CTAG. In the other patient
both examinations detected endoleak consistently, which
was however in the case of CTAG described as type II by
way of the inferior mesenteric artery and in the case of
CEUS the same endoleak was assessed as endoleak
appearing in the area of the stent graft branch. During
the follow-up control examination the endoleak was
identically interpreted as being of type II by way of the
inferior mesenteric artery.
(b) Size: When comparing the sizes of aneurysm sacks
measured during CTAG examinations and during ultra-
sound examinations, we observed differences (Table 2).
The maximum difference was 9 mm, the median 2 mm
and the average 2.68 mm. If statistical evaluation is
employed, these differences are signiﬁcant ( p < 0.001).
The values measured during CT examinations were higher.
In 9 patients more than 1 check-up was performed and
therefore we can compare the development of the sack
size. When we evaluated this development (growth/
stagnation/reduction in the sack size) based on CTAG
and based on CEUS, we observed consistency in 3 patients
only.
(c) Other complications: In the course of the check-ups no
examination revealed thrombosis, stenosis, break or
disconnection of the stent graft or its branch.
(d) Reintervention: None of the patients under monitoring
had to undergo a reintervention or a surgery due to
complications.
Table 2 – Diameters of aneurysmal sack measured by
CEUS and CT.
Control Diameter mm Control Diameter
mm
CT CEUS CT CEUS
1 64 65 15 45 45
2 55 50 16 85 76
3 42 38 17 78 74
4 67 69 18 56 54
5 45 42 19 49 50
6 85 80 20 56 49
7 78 74 21 46 46
8 55 55 22 66 60
9 55 55 23 54 55
10 51 51 24 46 45
11 40 38 25 44 42
12 55 53 26 52 52
13 42 42 27 44 41
14 68 62 28 78 74
Average 2.68 mm
Median 2 mm
p < 0.001
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In our set of patients there was one patient in whom we failed
to observe consistent results during the 1st postoperative
examination. CTAG examination described a II-type endoleak
by way of lumbar artery whereas CEUS failed to detect this
endoleak. During the follow-up examination not even CTAG
examination described endoleak and therefore the postopera-
tive CTAG examination ﬁnding was revised and it was
discovered that CTAG was false positive (because of calciﬁca-
tion of the aneurysm sack). Inconsistency between CTAG and
CEUS thus actually occurred in our set only once (3.7%
examination, 6.25% patients). Considering the fact that we
have been able to evaluate the development of the aneurysm
sack size in only 9 patients (in 3 patients 3 check-ups, in 6
patients 2 check-ups), we provide our observations only
without the statistical analysis of data related to such a small
set. In the case of both examinations (CTAG as well as CEUS),
the measurement of the sack size is executed by 1 evaluating
physician and we have only one measurement at our disposal.
All the aforementioned facts can be the source of errors. We do
not have any clear explanation for the statistically signiﬁcant
difference between the values measured by CTAG and CEUS.
The reason may be the methodology of measurement itself
and the selection of the measured area. This will be an object
for next retrospective analysis. Although the largest measured
difference was 9 mm, the median of the entire set is 2 mm and
the average difference is 2.68 mm. From the point of view of a
clinician these differences are not signiﬁcant and can be
caused by the above mentioned error of measurement.
In patients indicated for the treatment of AAA there is
always the risk of impairment of renal functions in relation to
the surgery. This risk is associated with both methods of
treatment – surgical as well as endovascular [10,11]. A numberof studies compared the results of both methods with a focus
on the postoperative impairment of renal functions. From this
point of view EVAR provides better results with infrarenal
ﬁxation and worse results are obtained in the case of standard
surgical treatment followed by EVAR with suprarenal ﬁxation
[5]. Based on additional studies it is possible to apply the
endovascular treatment to patients subject to an increased
risk of the impairment of renal functions with good results
[12]. The essence of this adverse effect is likely to be
multifactorial with contributions of ischaemia, impairment
of tubules epithelium and endothelium, the effect of oxygen
free radicals and the reduction in the synthesis of nitric oxide
[7]. The patient is exposed to this risk during standard
angiographic examination, computed tomography examina-
tion and also during every radiointervention surgery. As we
emphasized above, regular check-ups of patients treated by
the endovascular method are necessary. Although the risk of
malignant disease in relation to CT examination is not
signiﬁcantly increased in general population, the patients
who undergo CT examinations repeatedly are exposed to an
increased potential risk of malignant disease [6]. An alterna-
tive treatment of certain complications is again the radio-
intervention treatment. From this point of view we should try
to minimize the burden and potential risks arising from such
examinations. We have at our disposal several options of the
monitoring of patients who underwent EVAR. In most cases
CTAG examination is employed. This examination is associ-
ated with the aforementioned complications and with the
possibility of allergic reaction [9,13,14]. The same complica-
tions must be expected in the case of invasive angiography
with the use of iodine contrast medium where there are also
the risks of complications in the point of access – haemorrhage
and thrombosis. The innovated CT instruments and the new
regimes of CT examination improve the outputs of these
examinations and expedite the entire examination and in
addition allow smaller volumes of the contrast medium to be
used and result in the reduction in the ionizing radiation dose
[15]. Another tool for the monitoring of patients is a simple
X-ray photograph, which can reveal e.g. the migration of the
stent or a component thereof and also its break [16,17]. This
examination is easily available, cheap, but again the patient is
exposed to the effects of ionizing radiation even though
insigniﬁcant from the point of view of potential carcinogene-
sis. X-ray examination itself is not sufﬁcient for the purposes
of the monitoring of patients with stent grafts as it is not able
to reveal other complications and for this reason it is often
combined with ultrasound scans. Ultrasound examination
allows us to monitor the development of the aneurysm size in
time, it can display thrombosis and with the use of the Doppler
principle, it can detect endoleak as well [16,17]. If it is combined
with intravenous administration of contrast medium, its
ability to detect endoleak should be improved. With the use
of contrast medium, which is distributed in blood, we can
obtain improved images of for example perfusion of organs,
measure the blood ﬂow velocity, detect endoleak, etc. [18]. The
essence of the contrast medium for ultrasound examination
are microbubbles of gas. The chemical compositions inﬂu-
ences other properties of the contrast medium – elasticity
and hydrophilicity and the resulting rate of distribution and
above all elimination. The outer shell of bubbles can be formed
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can be oxygen, nitrogen or some heavy gases. The size of
such bubbles is usually 1–4 mm [19]. The possible risk of side
effects – alergoid reaction, because of usage of this contrast
medium is lower (1:10 000) than in CTAG. CEUS cannot be
used in childhood, pregnant women and in case of acute
coronary syndrome because of possible bradycardia. The
advantage of ultrasound examination is also the fact that it
is dynamic examination that allows real-time imaging. Using
this examination, we can monitor the development of the
aneurysm sack size, the presence of thrombosis and real-time
imaging and it may improve our ability to detect endoleak as
well. The use of such contrast medium does not aggravate the
risk of nephropathy. Expenses per examination in patients
after EVAR are by approximately 40% lower in the case of CEUS
compared to CTAG under conditions of the Teaching Hospital
in Pilsen.
Conclusion
In the light of experience it is obvious that the use of CEUS
within the framework of dispensary care for patients after
the endovascular treatment of infrarenal aortic aneurysm is
reliable in terms of the detection of potential endoleak. As
far as the issue of the evaluation of the development of the
aneurysm sack size is concerned, for the time being we are
not able to say for certain whether CEUS is sufﬁciently
reliable. If we evaluate the development in time, it seems to
be better to compare measurements obtained by the same
imaging method. If CEUS is used, we could reduce effectively
the cumulative doses of X-ray radiation to which our
patients are exposed together with other risks of potential
complications and adverse effects resulting from the inges-
tion of the iodine contrast medium necessary for computed
tomography examination. Even if the expenses necessarily
incurred in relation to the examination are considered, CEUS
seems to be more advantageous. However, CTAG as well as
standard angiography with the option of intervention
remain indispensable in respect of care for this group of
patients. This applies in particular to the conﬁrmation and
planning of the treatment of a serious complication
requiring a surgery or a radioinvasive solution. However,
for a reliable evaluation of the opted procedure – monitoring
of patients after EVAR using CEUS – it is necessary to have a
larger set of patients and more extensive experience proven
in several centres.
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